Insider · CIK 0001698082
Shah Nimish P
Reports to the SEC for 13 companies · NEW YORK, NY
Transactions
30
Companies
13
Filings
8
CIK
0001698082
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-09 | KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-09-03 | APGEApogee Therapeutics, Inc.D Disposition to Issuer | −$236M |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Non-Voting Common StockD Disposition to Issuer | −$911M |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2026-09-03 | APGEApogee Therapeutics, Inc. · Pre-Funded Warrants (Right to Buy)D Disposition to Issuer | — |
| 2026-06-09 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-10-10 | APGEApogee Therapeutics, Inc. · Pre-Funded Warrants (Right to Buy)P Purchase | +$15M |
| 2025-06-17 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-05 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-07-13 | APGEApogee Therapeutics, Inc.P Purchase | +$29.8M |
| 2023-07-13 | APGEApogee Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-03-23 | TILInstil Bio, Inc.C Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc.C Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc.C Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc.C Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc.C Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc.P Purchase | +$2.09M |
| 2021-03-23 | TILInstil Bio, Inc.P Purchase | +$209K |
| 2021-03-23 | TILInstil Bio, Inc.P Purchase | +$2.34M |
| 2021-03-23 | TILInstil Bio, Inc.P Purchase | +$968K |
| 2021-03-23 | TILInstil Bio, Inc.P Purchase | +$392K |
| 2021-03-23 | TILInstil Bio, Inc. · Series B Preferred StockC Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc. · Series B Preferred StockC Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc. · Series C Preferred StockC Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc. · Series C Preferred StockC Conversion | — |
| 2021-03-23 | TILInstil Bio, Inc. · Series C Preferred StockC Conversion | — |
| 2021-03-18 | TILInstil Bio, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Shah Nimish P0001193125-26-388144SEC(opens sec.gov)
- 4Shah Nimish P0001140361-26-035608SEC(opens sec.gov)
- 4Shah Nimish P0001104659-26-073061SEC(opens sec.gov)
- 4Shah Nimish P0001698082-25-000003SEC(opens sec.gov)
- 4Shah Nimish P0001104659-25-061277SEC(opens sec.gov)
- 4Shah Nimish P0001104659-24-069793SEC(opens sec.gov)
- 4Shah Nimish P0001104659-23-081730SEC(opens sec.gov)
- 4Shah Nimish P0001209191-21-023065SEC(opens sec.gov)
Companies
- Altimmune, Inc.10% OwnerALT
- Apogee Therapeutics, Inc.DirectorAPGE
- Bellerophon Therapeutics, Inc.10% Owner
- Cogent Biosciences, Inc.10% OwnerCOGT
- CONSTELLATION PHARMACEUTICALS INC10% Owner
- Instil Bio, Inc.DirectorTIL
- KalVista Pharmaceuticals, Inc.10% Owner
- Korsana Biosciences, Inc.DirectorKRSA
- Lycia Therapeutics, Inc.10% OwnerLYCA
- Oruka Therapeutics, Inc.10% OwnerORKA
- Shockwave Medical, Inc.10% Owner
- Tricida, Inc.10% Owner
- Vistagen Therapeutics, Inc.10% OwnerVTGN
Address
C/O VENROCK 7 BRYANT PARK, 23RD FLOOR
NEW YORK, NY, 10018